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Introduction
Lung transplant recipients are at high risk of invasive
fungal disease (IFD), particularly invasive aspergillosis
and candidiasis. In contrast to liver transplant patients,
no randomized controlled trials or international guide-
lines on antifungal prophylaxis in the lung transplant
population exist.
Objective
We performed a meta-analysis to determine whether
antifungal prophylaxis reduces the rate of fungal infec-
tions after lung transplant.
Methods
MEDLINE, EMBASE, CENTRAL/CCTR, Google Scholar,
and reference lists of relevant articles were searched for
full text articles in English from 1990-2014. Assessments
for eligibility, relevance, study validity and data extraction
were performed by two reviewers independently using
prespecified criteria. The primary outcome was incidence
of fungal infections (FI).
Results
A total of six eligible observational studies with a total of
748 patients were identified (five comparing universal
with no prophylaxis and one comparing targeted with no
prophylaxis): 448 patients were treated with antifungal
prophylaxis and 300 patients without prophylaxis served
as controls. The pooled Odds ratio (OR) for fungal infec-
tion (62 FI in the intervention arm, 82 in the control
group) was 0.234 [random effects model, 95% confidence
interval (CI) 0.097-0.564, p = 0.001, z = -3.237]. Pooled
studies were characterized by substantial heterogeneity
(I2 66.64%). As mortality and rate of complications of
antifungal medication were only infrequently reported,
a pooled analysis for these outcomes could not be
performed.
Conclusion
The present study suggests that universal antifungal pro-
phylaxis reduces incidence of FI after lung transplant.
However included studies are limited by small sample
size, single center structure without randomization,
mixed population (including heart transplant, single and
double lung transplant) and heterogeneity due to varia-
tions in immunosuppression, type and duration of anti-
fungal prophylaxis and incidence of fungal infection.
Therefore, the optimal drug, dosage and duration of
prophylaxis remain uncertain and there is a clear need
for an adequately powered, prospective randomized con-
trolled trial.
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